Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liquid biopsy approaches to capture tumor evolution and clinical outcomes during cancer immunotherapy
Lavanya Sivapalan, Joseph C. Murray, Jenna VanLiere Canzoniero, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 1, pp. e005924-e005924
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results
Valsamo Anagnostou, Cheryl Ho, Garth Nicholas, et al.
Nature Medicine (2023) Vol. 29, Iss. 10, pp. 2559-2569
Open Access | Times Cited: 48
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results
Amy Rappaport, Chrisann Kyi, Monica Lane, et al.
Nature Medicine (2024) Vol. 30, Iss. 4, pp. 1013-1022
Closed Access | Times Cited: 26
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses
Ronan J. Kelly, Blair V. Landon, Ali H. Zaidi, et al.
Nature Medicine (2024) Vol. 30, Iss. 4, pp. 1023-1034
Open Access | Times Cited: 25
Beyond blood: Advancing the frontiers of liquid biopsy in oncology and personalized medicine
Ying Bao, Dejing Zhang, Huihui� Guo, et al.
Cancer Science (2024) Vol. 115, Iss. 4, pp. 1060-1072
Open Access | Times Cited: 15
Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision
Leisha A. Emens, Pedro Romero, Ana C. Anderson, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 6, pp. e009063-e009063
Open Access | Times Cited: 14
Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer
Lavanya Sivapalan, Wade T. Iams, Zineb Belcaid, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 12, pp. 2310-2323
Open Access | Times Cited: 29
Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA
Nicholas P. Semenkovich, Jeffrey J. Szymanski, Noah Earland, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006284-e006284
Open Access | Times Cited: 27
Network approach in liquidomics landscape
Daniele Santini, Andrea Botticelli, Antonio Galvano, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 21
Liquid biopsy: Cell-free DNA based analysis in breast cancer
Konstantinos Venetis, Giulia Cursano, Carlo Pescia, et al.
The Journal of Liquid Biopsy (2023) Vol. 1, pp. 100002-100002
Open Access | Times Cited: 20
ctDNA for the Evaluation and Management of EGFR-Mutant Non-Small Cell Lung Cancer
Aakash Desai, Tadana A. Vázquez, Keishla M. Arce, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 940-940
Open Access | Times Cited: 10
New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication
Sha Qin, Bin Xie, Qingyi Wang, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 8
Exploiting temporal aspects of cancer immunotherapy
Rachael M. Zemek, Valsamo Anagnostou, Inês Pires da Silva, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 7, pp. 480-497
Closed Access | Times Cited: 8
Pushing the Boundaries of Liquid Biopsies for Early Precision Intervention
Valsamo Anagnostou, Victor E. Velculescu
Cancer Discovery (2024) Vol. 14, Iss. 4, pp. 615-619
Open Access | Times Cited: 6
Longitudinal genomic profiling using liquid biopsies in metastatic nonsquamous NSCLC following first line immunotherapy
Haolun Ding, Min Yuan, Yaning Yang, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Research Progress of CRISPR Technology for Accurate Diagnosis and Treatment in Oncology
继婷 邓
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 787-796
Closed Access
Advancing Veterinary Oncology: Next-Generation Diagnostics for Early Cancer Detection and Clinical Implementation
Aya Hasan Alshammari, Takuya Oshiro, Umbhorn Ungkulpasvich, et al.
Animals (2025) Vol. 15, Iss. 3, pp. 389-389
Open Access
Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden
Luís Paz-Ares, Marina Chiara Garassino, Yuanbin Chen, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 4, pp. 824-835
Open Access | Times Cited: 19
Reviewing the progress of cancer research in the USA
Israel Osejie Okoduwa, Bankole Ibrahim Ashiwaju, Jane Osareme Ogugua, et al.
World Journal of Biology Pharmacy and Health Sciences (2024) Vol. 17, Iss. 2, pp. 068-079
Open Access | Times Cited: 5
Research on liquid biopsy for cancer: A bibliometric analysis
Shitao Jiang, Y. Liu, Yiyao Xu, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e14145-e14145
Open Access | Times Cited: 14
liquid biopsy holds a promising approach for the early detection of cancer: Current information and future perspectives
Abdullah M. Shbeer, Ibrahim Ahmed Robadi
Pathology - Research and Practice (2024) Vol. 254, pp. 155082-155082
Closed Access | Times Cited: 3
Association between plasma circulating tumor DNA and the prognosis of esophageal cancer patients: a meta-analysis
Haowen Zhang, Tao Jin, Yuhao Peng, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 3
Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab
Ying‐Chun Shen, Tsung‐Hao Liu, Alan Nicholas, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 34, pp. 4060-4070
Closed Access | Times Cited: 3
Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
Joseph C. Murray, Lavanya Sivapalan, Karlijn Hummelink, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 2, pp. 389-403
Open Access | Times Cited: 8
Prospects of liquid biopsy in the prognosis and clinical management of gastrointestinal cancers
Deepankar Mondal, Sapnita Shinde, Vibha Sinha, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 2
Immunotherapy in patients with brain metastasis: advances and challenges for the treatment and the application of circulating biomarkers
Elena Brozos-Vázquez, Claudia Rodríguez-López, A. Cortegoso-Mosquera, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top